379TiP TEM-GBM: A phase I-IIa clinical study of genetically modified Tie-2-expressing monocytes in patients with glioblastoma multiforme

Autor:	F. Di Meco, Stefania Mazzoleni, Luigi Naldini, Mariagrazia Bruzzone, Marco Saini, Carlo Russo, Roberto Pallini, Francesca Farina, Marica Eoli, G. Finocchiaro, Elena Anghileri, Federico G. Legnani, Bianca Pollo, Fabio Ciceri, Paolo Ferroli, Matteo Carrabba, Valeria Cuccarini, Bernhard Gentner, Alessandro Olivi, Alessia Capotondo
Rok vydání:	2021
Předmět:	Clinical study Oncology business.industry medicine Cancer research In patient Hematology medicine.disease business Glioblastoma Genetically modified organism
Zdroj:	Annals of Oncology. 32:S528
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2021.08.043
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::805e0661cbe916adda51e985bede9a1c https://doi.org/10.1016/j.annonc.2021.08.043 Zobrazit plný text záznamu